-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320

Benzinga·10/29/2025 17:38:58
Listen to the news
UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and lowers the price target from $325 to $320.